Remdesivir in a pregnant patient with COVID-19 pneumonia

Authors :: Ranadheer Dande
Anum Qureshi
Kia Persaud
Chahat Puri
Sajida Zulfiqar
Shankar Awasthi
Source :: Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 1, Pp 103-106 (2021)
Publication Year :: 2021
Publisher :: Greater Baltimore Medical Center, 2021.
Abstract: Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.